| Literature DB >> 28239173 |
Lakhmir S Chawla1, Rinaldo Bellomo2, Azra Bihorac3, Stuart L Goldstein4, Edward D Siew5, Sean M Bagshaw6, David Bittleman7, Dinna Cruz8, Zoltan Endre9, Robert L Fitzgerald7, Lui Forni10, Sandra L Kane-Gill11, Eric Hoste12, Jay Koyner13, Kathleen D Liu14, Etienne Macedo8, Ravindra Mehta8, Patrick Murray15, Mitra Nadim16, Marlies Ostermann17, Paul M Palevsky18,19, Neesh Pannu6, Mitchell Rosner20, Ron Wald21, Alexander Zarbock22, Claudio Ronco23, John A Kellum24.
Abstract
Consensus definitions have been reached for both acute kidney injury (AKI) and chronic kidney disease (CKD) and these definitions are now routinely used in research and clinical practice. The KDIGO guideline defines AKI as an abrupt decrease in kidney function occurring over 7 days or less, whereas CKD is defined by the persistence of kidney disease for a period of >90 days. AKI and CKD are increasingly recognized as related entities and in some instances probably represent a continuum of the disease process. For patients in whom pathophysiologic processes are ongoing, the term acute kidney disease (AKD) has been proposed to define the course of disease after AKI; however, definitions of AKD and strategies for the management of patients with AKD are not currently available. In this consensus statement, the Acute Disease Quality Initiative (ADQI) proposes definitions, staging criteria for AKD, and strategies for the management of affected patients. We also make recommendations for areas of future research, which aim to improve understanding of the underlying processes and improve outcomes for patients with AKD.Entities:
Mesh：
Year: 2017 PMID： 28239173 DOI： 10.1038/nrneph.2017.2
Source DB: PubMed Journal: Nat Rev Nephrol ISSN： 1759-5061 Impact factor: 28.314